Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 711.25
+5.60 (0.79%)
Mar 10, 2026, 3:20 PM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 16,571 employees as of March 31, 2025. The number of employees increased by 1,713 or 11.53% compared to the previous year.
Employees
16,571
Change (1Y)
1,713
Growth (1Y)
11.53%
Revenue / Employee
4.39M INR
Profits / Employee
379.55K INR
Market Cap
138.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 16,571 | 1,713 | 11.53% |
| Mar 31, 2024 | 14,858 | 265 | 1.82% |
| Mar 31, 2023 | 14,593 | 2,377 | 19.46% |
| Mar 31, 2022 | 12,216 | 56 | 0.46% |
| Mar 31, 2021 | 12,160 | 584 | 5.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Akums Drugs and Pharmaceuticals | 7,536 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Gland Pharma | 4,351 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Wockhardt | 2,296 |
Alembic Pharmaceuticals News
- 19 hours ago - Alembic Pharmaceuticals incorporates Thailand subsidiary with 99.99% stake - Business Upturn
- 4 days ago - Alembic Pharma reports first U.S. prescription sale of Pivya after commercial launch - Business Upturn
- 12 days ago - Alembic Pharma secures USFDA final approval for Lamotrigine Orally Disintegrating Tablets - Business Upturn
- 14 days ago - Alembic Pharmaceuticals gets USFDA nod for Efinaconazole Topical Solution, 10% - Business Upturn
- 14 days ago - Pharma sector stocks down today, Feb 24: AstraZeneca Pharma falls 1.72%, Alembic Pharma down 1.38%, Gland Pharma drops 1.24% - Business Upturn
- 4 weeks ago - Alembic Pharmaceuticals Ltd (BOM:533573) Q3 2026 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 4 weeks ago - Q3 2026 Alembic Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Alembic Pharmaceuticals gets USFDA final approval for Carbidopa, Levodopa and Entacapone tablets - Business Upturn